Immunity to cancer through immune recognition of altered self: studies with melanoma.
about
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsUsing virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resectionFunctional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.Cytotoxic T lymphocyte responses against melanocytes and melanoma.Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.Antitumor cytotoxic T-cell response induced by a survivin peptide mimicAnti-tumor antibodies in ovarian cancer.Prevalence of antitumor antibodies in laying hen model of human ovarian cancerChallenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.Enhanced interferon-gamma secretion and antitumor activity of T-lymphocytes activated by dendritic cells loaded with glycoengineered myeloma antigens.Novel vaccines for glioblastoma: clinical update and perspective.Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM).Immune rejection of mouse tumors expressing mutated self.
P2860
Q33507532-7A40CE46-50DE-4733-A9CB-F3CAA5A15898Q33936327-C00C3AF1-3041-4120-A4E1-977E603FFF6FQ34198856-E2BA48EA-9DEE-4096-87C6-C7EA9C485332Q34625208-6A6396BF-E750-4BBF-B10B-2D5A1DC92AD1Q34764685-B40E3C8C-1879-451A-8F72-081A5FC2046CQ35172610-CD1CD0D0-BC30-4348-9D7D-3B6E04158415Q35345202-BF339DDF-AC65-4EB2-BEE1-9E11913B91C9Q36155913-6F732896-CCEA-4E5F-B5DD-D7CD53157339Q36232263-E07C8AB6-7ABE-441E-935D-C88F3B63C84CQ37436255-AA376EF3-D0D6-4343-BA01-51F3C9C2EACAQ38187480-E543E9C0-F2E8-4EBD-AEE2-0E497EA1EEAFQ38548199-09B5A6F9-DED3-4951-8CBA-B1A8085D09B9Q39043417-B721FAAB-0C2C-49AB-942F-88857955BBCAQ40385940-6DD3BD7C-9C44-4230-8D90-7F17630FADBBQ42145055-D72322F7-CC07-4107-9866-B5FF1BC1C7DC
P2860
Immunity to cancer through immune recognition of altered self: studies with melanoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@ast
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@en
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@nl
type
label
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@ast
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@en
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@nl
prefLabel
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@ast
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@en
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@nl
P2093
P1476
Immunity to cancer through immune recognition of altered self: studies with melanoma.
@en
P2093
Alan N Houghton
Jedd D Wolchok
José A Guevara-Patiño
Mary Jo Turk
P304
P356
10.1016/S0065-230X(03)90005-4
P577
2003-01-01T00:00:00Z